These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Pharmacological modulation of AMPA receptor rescues social impairments in animal models of autism. Kim JW; Park K; Kang RJ; Gonzales ELT; Kim DG; Oh HA; Seung H; Ko MJ; Kwon KJ; Kim KC; Lee SH; Chung C; Shin CY Neuropsychopharmacology; 2019 Jan; 44(2):314-323. PubMed ID: 29899405 [TBL] [Abstract][Full Text] [Related]
4. Zelquistinel Is an Orally Bioavailable Novel NMDA Receptor Allosteric Modulator That Exhibits Rapid and Sustained Antidepressant-Like Effects. Burgdorf JS; Zhang XL; Stanton PK; Moskal JR; Donello JE Int J Neuropsychopharmacol; 2022 Dec; 25(12):979-991. PubMed ID: 35882204 [TBL] [Abstract][Full Text] [Related]
5. Improvement of autistic-like behaviors in adult rats prenatally exposed to valproic acid through early suppression of NMDA receptor function. Mohammadi S; Asadi-Shekaari M; Basiri M; Parvan M; Shabani M; Nozari M Psychopharmacology (Berl); 2020 Jan; 237(1):199-208. PubMed ID: 31595334 [TBL] [Abstract][Full Text] [Related]
6. Agmatine rescues autistic behaviors in the valproic acid-induced animal model of autism. Kim JW; Seung H; Kim KC; Gonzales ELT; Oh HA; Yang SM; Ko MJ; Han SH; Banerjee S; Shin CY Neuropharmacology; 2017 Feb; 113(Pt A):71-81. PubMed ID: 27638451 [TBL] [Abstract][Full Text] [Related]
7. NEXMIF/KIDLIA Knock-out Mouse Demonstrates Autism-Like Behaviors, Memory Deficits, and Impairments in Synapse Formation and Function. Gilbert J; O'Connor M; Templet S; Moghaddam M; Di Via Ioschpe A; Sinclair A; Zhu LQ; Xu W; Man HY J Neurosci; 2020 Jan; 40(1):237-254. PubMed ID: 31704787 [TBL] [Abstract][Full Text] [Related]
15. From Mouse to Man: N-Methyl-d-Aspartic Acid Receptor Activation as a Promising Pharmacotherapeutic Strategy for Autism Spectrum Disorders. Deutsch SI; Burket JA Med Clin North Am; 2023 Jan; 107(1):101-117. PubMed ID: 36402493 [TBL] [Abstract][Full Text] [Related]
16. Effects of extended-release 7-nitroindazole gel formulation treatment on the behavior of Shank3 mouse model of autism. Abdel-Haq M; Ojha SK; Hamoudi W; Kumar A; Tripathi MK; Khaliulin I; Domb AJ; Amal H Nitric Oxide; 2023 Nov; 140-141():41-49. PubMed ID: 37714296 [TBL] [Abstract][Full Text] [Related]
19. Diminished social interaction incentive contributes to social deficits in mouse models of autism spectrum disorder. Rein B; Yan Z; Wang ZJ Genes Brain Behav; 2020 Jan; 19(1):e12610. PubMed ID: 31602784 [TBL] [Abstract][Full Text] [Related]
20. Epothilone D Modulates Autism-like Behaviors in the BTBR Mouse Model of Autism Spectrum Disorder. Zhao M; Chang Q; Yang H; Wang M; Liu Y; Lv N; Lei Q; Wei H Neuroscience; 2022 May; 490():171-181. PubMed ID: 35227832 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]